Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 18, 2013

Primary Completion Date

October 5, 2016

Study Completion Date

October 5, 2016

Conditions
Mucopolysaccharidosis (MPS)Hunter Syndrome
Trial Locations (7)

27514

University of North Carolina Division of Genetics and Metabolism, Chapel Hill

28009

Hospital Infantil Universitario, Madrid

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

94609

Childrens Hospital & Research Center Oakland, Oakland

B1629ODT

Hospital Universitario Austral, Pilar

04530

Instituto Nacional De Pediatria, Mexico City

Unknown

Central Manchester University Hospitals NHS Foundation Trust Willink Biochemical Genetics Unit, St. Mary's Hospital, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY